| Author Search Results for "Allen Loyd V Jr" |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Prescription - Dermatology and Wound Care
Allen Loyd V Jr
|
Nov/Dec 2024
Pg. 452-453
|
Benzoyl Peroxide 10% Gel
Allen Loyd V Jr
|
Nov/Dec 2024
Pg. 482
|
Cohen’s Rectal Ointment
Allen Loyd V Jr
|
Nov/Dec 2024
Pg. 483
|
Diaper Rash Cream with Miconazole
Allen Loyd V Jr
|
Nov/Dec 2024
Pg. 484
|
Emanuel Butt Paste
Allen Loyd V Jr
|
Nov/Dec 2024
Pg. 485
|
Lidocaine Hydrochloride 2% Viscous Oral Topical Solution
Allen Loyd V Jr
|
Nov/Dec 2024
Pg. 486
|
Riley Butt Cream
Allen Loyd V Jr
|
Nov/Dec 2024
Pg. 487
|
Sucralfate and Hyaluronic Acid Ointment
Allen Loyd V Jr
|
Nov/Dec 2024
Pg. 488
|
Tetracaine Hydrochloride 2% Topical Solution
Allen Loyd V Jr
|
Nov/Dec 2024
Pg. 489
|
Tetracaine 4% and Menthol 5% Topical Gel
Allen Loyd V Jr
|
Nov/Dec 2024
Pg. 490
|
Wound Gel
Allen Loyd V Jr
|
Nov/Dec 2024
Pg. 491
|
Prescription: Technology in Compounding
Allen Loyd V Jr
|
Sep/Oct 2024
Pg. 356
|
Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Allen Loyd V Jr
|
Sep/Oct 2024
Pg. 358-362
|
Standard Operating Procedure for Assignment of Beyond-Use Dates
Allen Loyd V Jr
|
Sep/Oct 2024
Pg. 374-375
|
Quality Control: Water Activity Considerations for Beyond-use Dates
Allen Loyd V Jr
|
Sep/Oct 2024
Pg. 376-381
|
Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2024
Pg. 396
|
Diclofenac Sodium 1% Soft-Patch Gel
Allen Loyd V Jr
|
Sep/Oct 2024
Pg. 397
|
Diclofenac Sodium 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
|
Sep/Oct 2024
Pg. 398
|
Fluconazole 2% Topical Microemulsion
Allen Loyd V Jr
|
Sep/Oct 2024
Pg. 399
|
Lidocaine Hydrochloride 2% Viscous Oral Topical Solution
Allen Loyd V Jr
|
Sep/Oct 2024
Pg. 400
|
Piroxicam 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
|
Sep/Oct 2024
Pg. 401
|
Prescription: Pediatric/Geriatric
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 268-269
|
Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 296-297
|
Sterile Basics of Compounding: Repackaging, Part 1
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 298-303
|
Cholestyramine 6.5% Ointment
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 306
|
Clozapine 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 307
|
Gabapentin 5% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 308
|
Ivermectin 0.8% Creme Rinse
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 309
|
Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 310
|
Milk of Magnesia Concentrate, Unflavored
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 311
|
Natural Head Lice Repellant Spray
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 312
|
Niacinamide 4% Acne Gel
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 313
|
Promethazine Hydrochloride 50 mg/mL in PLO Gel
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 314
|
Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 315
|
Prescription: Veterinary
Allen Loyd V Jr
|
May/Jun 2024
Pg. 180
|
Amlodipine Besylate Veterinary Suspension
Allen Loyd V Jr
|
May/Jun 2024
Pg. 242
|
Carprofen 2.5-mg/mL Oral Suspension, Veterinary
Allen Loyd V Jr
|
May/Jun 2024
Pg. 243
|
Diltiazem 5% in Lipoderm, Veterinary
Allen Loyd V Jr
|
May/Jun 2024
Pg. 244
|
Miconazole 1% Ophthalmic Solution, Veterinary
Allen Loyd V Jr
|
May/Jun 2024
Pg. 245
|
Prescription: Compounding for Pain Management Patients
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 92
|
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel GEL
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 130
|
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 131
|
Analgesic Compound Lotion, Clear
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 132
|
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 133
|
Diclofenac Sodium 1% Soft-patch Gel
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 134
|
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 135
|
Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 136
|
Rectal Rockets: Lidocaine 3%, Hydrocortisone 2%
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 137
|
PreScription: IJPC is now all Digital
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 4
|
Estradiol 0.1% Vaginal Solution
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 58
|
Estradiol 1-mg/0.1-g Topical Cream
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 59
|
Estriol and Estradiol 1.25, 2.5, and 5 mg (BiEst) Capsules
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 60
|
Progesterone 10% Topical Cream
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 61
|
Progesterone 100-mg/mL Sublingual Drops
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 62
|
Progesterone Vaginal Suppositories (Fatty Acid Base)
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 63
|
Testosterone 1 mg/0.1 mL in a PLO Gel
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 64
|
Testosterone 2-mg and Dehydroepiandrosterone (DHEA) 15-mg Troches
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 65
|
Testosterone 10-mg/0.1-mL Sublingual Drops
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 66
|
Triple Estrogen 2.5 mg Tablet Triturates
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 67
|
PreScription: Changes Are Coming!
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 444
|
Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 474-481
|
Sterile Basics of Compounding: Allowable Endotoxin Levels in Parenteral Preparations
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 483-486
|
Curcumin 1% Intranasal Mucoadhesive Gel
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 490
|
Hyaluronidase Injection
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 491
|
Hydrocortisone 2% and Menthol 0.5% in VersaPro Cream Base
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 492
|
Salicylic Acid 30% Gel
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 493
|
PreScription: Data Security/Breaches: What is the Effect on Pharmacies?
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 356
|
Excipients and Adverse Events
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 382-385
|
Basics of Compounding: Compounding Foams
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 386-395
|
Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 397-409
|
Crotamiton 10% Cream
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 412
|
Fluconazole 1% Thermoresponsive Gel
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 414-415
|
Hydrocortisone 2% in Versapro Cream
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 416
|
Idoxuridine 5% in Dimethyl Sulfoxide
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 417
|
Ipratropium Bromide 0.05% Nasal Spray
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 418-419
|
Nitazoxanide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 420
|
Povidone Iodine Lotion
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 421
|
Silver Sulfadiazine 1% and Hydrocortisone 2% Gel
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 422-423
|
PreScription: Our Lives Are Shaped by the Decisions We Make!
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 268
|
Nonsterile Basics of Compounding: Compounding with Antioxidants, Part 1: An Overview
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 295-302
|
Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 305-313
|
Chlorhexidine and Cetrimide Lotion
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 316
|
Clobazam 5-mg/mL Suspension
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 317-318
|
Clotrimazole 1% and Betamethasone Dipropionate 0.05% Cream
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 319
|
Cyclosporine Topical Gel Formulation
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 320-321
|
Dexamethasone 1 mg/mL in Oral Mix SF
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 322
|
Lamotrigine 1 mg/mL in SuspendIt Plus
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 323
|
Levofloxacin 0.5% Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 324-325
|
Losartan Potassium 2.5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 326
|
Nystatin Oromucosal Gel
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 327
|
Rifampin 10-mg/mL Nasal Drops
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 328
|
Trihexyphenidyl Hydrochloride 1-mg/mL Oral Liquid, Alcohol-free
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 329
|
PreScription: Shortages Continue--Compounding Pharmacies Fill the Gap…Again!
Allen Loyd V Jr
|
May/Jun 2023
Pg. 180
|
Nonsterile Basics of Compounding: Compounding with Humectants
Allen Loyd V Jr
|
May/Jun 2023
Pg. 218-221
|
Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Allen Loyd V Jr
|
May/Jun 2023
Pg. 223-229
|
Acetaminophen 500-mg/mL Rectal Solution
Allen Loyd V Jr
|
May/Jun 2023
Pg. 232-233
|
Doxycycline 166.7-mg/mL Oral Suspension (Veterinary)
Allen Loyd V Jr
|
May/Jun 2023
Pg. 234
|
Gentamicin 480-mg/1000-mL Bladder Irrigation
Allen Loyd V Jr
|
May/Jun 2023
Pg. 235
|
Methylene Blue 5-mg Capsules
Allen Loyd V Jr
|
May/Jun 2023
Pg. 236
|
Migraine Headache Suppositories
Allen Loyd V Jr
|
May/Jun 2023
Pg. 237
|
Nifedipine, Lidocaine, and Nitroglycerin Suppositories
Allen Loyd V Jr
|
May/Jun 2023
Pg. 238
|
Nystatin Oromucosal Viscous Suspension
Allen Loyd V Jr
|
May/Jun 2023
Pg. 239
|
PreScription: Amoxicillin Shortage Continues: Compounding Pharmacies Filling the Gap!
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 92
|
Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 123-139
|
Aminohippurate Sodium 250 mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 142
|
Amphotericin B 0.1% Topical Microemulsion
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 143
|
Aphthous Ulcer Gel
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 144
|
Bethanechol 0.01% in Lanolin 10% and White Petrolatum 90%
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 145
|
Cyclosporine Topical Microemulsion
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 146
|
Hypochlorous Acid 0.01% Oral Rinse
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 147
|
Nystatin, Lidocaine, Hydrocortisone, and Chlorhexidine Oral Rinse
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 148
|
Pilocarpine Hydrochloride 0.3% w/v Solution
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 149-151
|
Sacrosidase 8,500 Units Per mL Oral Solution
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 152
|
Timolol 0.125%/Mucolox 15%/0.9% Normal Saline Nasal Spray
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 153
|
PreScription: New Drug Approvals 2022 and Compounding Opportunities
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 4
|
Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 30-37
|
Acetaminophen 10 mg/mL for Rectal Use
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 50
|
Clozapine 20 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 51
|
Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 52
|
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 53
|
Manning's Liniment
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 54
|
Mayer's Ointment
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 55
|
Povidone Iodine 100-mg/mL Solution/Spray
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 56
|
Psoriasis Topical Ointment
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 57
|
Suspension Solution, Sugar Free
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 58-59
|
PreScription: Compounded Drugs Often Become Manufactured Drugs
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 444
|
Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 446-466
|
Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 490-495
|
Bacitracin 0.01% and Phenol 0.1% in Cetaphil Lotion
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 508
|
Curcumin 2% Topical Gel
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 509
|
Diazoxide 10-mg/mL in Oral Mix SF
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 510
|
Enrofloxacin 11.35 mg/mL in Ora-Blend, Veterinary
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 511
|
Flucytosine 50 mg/mL in Oral-Sweet and Ora-Plus
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 512
|
Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 513
|
Miller's Modified Mouthwash
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 514
|
Potassium Alum 1% Bladder Irrigation for Hemorrhagic Cystitis (Low-Medium Risk Compounding)
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 515
|
PreScription: A New Dosage Form
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 356
|
Compounding with Biotechnology Products, Part 1: General Considerations
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 385-395
|
Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 400-408
|
Amphotericin B 3% Otic Gel
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 422
|
Ascorbic acid 5% Topical Microemulsion
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 423
|
Chlorhexidine Diacetate 2% Topical Gel
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 424
|
Clindamycin Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 425
|
Clotrimazole 10-mg Troches
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 426
|
Cysteamine Hydrochloride 100 mg/mL Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 427
|
Hydrogen Peroxide 1.5% with Sodium Fluoride 0.5-mg/mL Oral Rinse
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 428
|
Lansoprazole 3-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 429
|
Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 430
|
Methylcobalamin 2-mg/mL Nasal Spray
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 431
|
PreScription: Pharmacy and Drug Information
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 268
|
Basics: Hollow-type Suppositories
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 302-307
|
Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 318
|
Cetrimide Lotion
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 319
|
Dexamethasone 1 mg/mL in Oral Mix
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 320
|
Furosemide 5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 321-322
|
Hydralazine Hydrochloride 10 mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 323-324
|
Indomethacin 1% Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 325-326
|
Nystatin 250,000-unit Frozen Popsicles
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 327
|
Povidone Iodine 100-mg/mL Solution/Spray
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 328
|
Psoriasis Topical Ointment
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 329
|
PreScription: Standing in the Gap
Allen Loyd V Jr
|
May/Jun 2022
Pg. 180
|
Compounding for Investigational and Clinical Studies
Allen Loyd V Jr
|
May/Jun 2022
Pg. 201-209
|
Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes
Allen Loyd V Jr
|
May/Jun 2022
Pg. 214-217
|
Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Allen Loyd V Jr
|
May/Jun 2022
Pg. 219-228
|
Alendronate Sodium 1% Topical Dental Gel
Allen Loyd V Jr
|
May/Jun 2022
Pg. 232
|
Azstarys in Ora-Blend Single Dose
Allen Loyd V Jr
|
May/Jun 2022
Pg. 233
|
Candesartan Cilexitil 1 mg/mL Syrup
Allen Loyd V Jr
|
May/Jun 2022
Pg. 234
|
Chloral Hydrate 70 mg/mL Syrup
Allen Loyd V Jr
|
May/Jun 2022
Pg. 235
|
Cinnarizine 1 mg/mL in Oral Medium-Chain Triglycerides Anhydrous Vehicle
Allen Loyd V Jr
|
May/Jun 2022
Pg. 236
|
Clobazam 1 mg/mL in Oral-Mix Suspension
Allen Loyd V Jr
|
May/Jun 2022
Pg. 237
|
Metronidazole 7.5 mg/mL Topical Oil-in-Water Microemulsion
Allen Loyd V Jr
|
May/Jun 2022
Pg. 238
|
Nitrazepam 1 mg/mL Oral Solution
Allen Loyd V Jr
|
May/Jun 2022
Pg. 239
|
Sirolimus 0.1% Ointment
Allen Loyd V Jr
|
May/Jun 2022
Pg. 240
|
Valganciclovir 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
|
May/Jun 2022
Pg. 241
|
PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry"
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 92
|
Quality Control: Photodocumentation in Pharmacy Compounding
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 116-117
|
Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 118-126
|
Sterile Basics of Compounding: Methods of Sterilization and Depyrogenation
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 129-136
|
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 140
|
Codeine Phosphate 3 mg/mL in Ora-Sweet
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 141
|
Ketoconazole 2%, Terbenafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 142
|
Lorazepam 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 143
|
Mesalamine 100-mg/mL Suspension Enema
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 144
|
Naproxen 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 145
|
Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 146
|
Phenytoin 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 147
|
Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 148
|
Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 149
|
PreScription: IJPC--Starting Year 26
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 4
|
Editorial: Should All Pharmacists Compound?
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 24-28
|
Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 34-38
|
Sterile Basics: Compounding Sterile Preparations with Cyclodextrins
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 41-49
|
Aluminum Chloride 6.25% in Anhydrous Alcohol
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 52
|
Ascorbic Acid 10% in Anhydrous PEG ointment
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 53
|
Deoxyarbutin 3% Anhydrous Emulsion
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 54
|
Diclofenac Sodium 1%-15% Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 55
|
Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 56
|
Mometasone Furoate 0.1% Lotion
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 57
|
PreScription: IJPC -- Twenty-Five Year Anniversary
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 444
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 12: Sorbents (Adsorbents and Absorbents)
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 486-489
|
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 491-496
|
Domperidone 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 500
|
Kayexalate in Lactulose
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 501
|
Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 502
|
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 503
|
Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 504
|
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 505
|
Quetiapine Fumarate 10 mg/mL in Ora-Blend
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 506
|
Shari's Burn Cream
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 507
|
Sulfadiazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 508
|
Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 509
|
PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800>
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 356
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 396-400
|
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 403-408
|
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 412
|
Cilazapril 1-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 413
|
Clonidine 0.01-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 414
|
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 415
|
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 416
|
Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 417
|
Imipramine Hydrochloride 5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 418
|
Mycophenolate Mofetil 50-mg/mL in Ora-Plus:Cherry Syrup Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 419
|
Sorafenib 20-mg/mL in Oil Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 420
|
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 421
|
PreScription: Endemics, Epidemics, and Pandemics
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 268
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 304-309
|
Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 311-317
|
Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 320
|
Atomoxetine 4-mg/mL Oral Solution/Suspension
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 321
|
BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel)
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 322
|
Budesonide 0.0.25% Mucoadhesive Gel
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 323
|
Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 324
|
Hydrocortisone 2-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 325
|
Moh's Paste, Modified
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 326
|
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 327
|
Tacrolimus 0.1% Topical Microemulsion
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 328
|
Valsartan 4-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 329
|
PreScription: The Ethical Pharmacist
Allen Loyd V Jr
|
May/Jun 2021
Pg. 180
|
Basics of Compounding: Excipients Used in Nonsterile Compounding: Diluents
Allen Loyd V Jr
|
May/Jun 2021
Pg. 218-221
|
Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
|
May/Jun 2021
Pg. 222-229
|
Levofloxacin 50-mg/mL in Ora-Plus and Strawberry Syrup Suspension
Allen Loyd V Jr
|
May/Jun 2021
Pg. 232
|
Naltrexone Hydrochloride 0.5 mg/mL and 5.0 mg/mL in SuspendIt Suspension
Allen Loyd V Jr
|
May/Jun 2021
Pg. 233
|
Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension
Allen Loyd V Jr
|
May/Jun 2021
Pg. 234
|
Temozolomide 10 mg/mL in Oral Mix SF Suspension
Allen Loyd V Jr
|
May/Jun 2021
Pg. 235
|
PreScription: The Past (-->2020), The Present, and The Future (2021-->)
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 92
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 8: Humectants
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 126-128
|
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 131-139
|
Amlodipine 1-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 142
|
Canine Soft Chew Base (Veterinary)
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 143
|
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 144
|
Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 145
|
PreScription: The NASEM cBHT Report, Part 2
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 4
|
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 31-38
|
Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 42
|
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 43
|
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 44
|
Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 45
|
Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 46
|
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 47
|
PreScription: The NASEM cBHT Report, Part 1
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 444
|
NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 446-448
|
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 473-478
|
Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 356
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 7: Compounding with Surfactants
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 388-395
|
Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 397-402
|
Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection
(Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection
(Vet-Mouse)
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 406
|
Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 407
|
PreScription: COVID-19 and Compounding Pharmacists
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 268
|
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 305-309
|
Benzonatate 50 mg/mL in Ora-Sweet
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 312
|
Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 313
|
Doxepin Hydrochloride 5% in Cetaphil Cream
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 314
|
Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 315
|
Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 316
|
Hydroxyzine (Pamoate) 25-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 317
|
Lisinopril 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 318
|
Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 319
|
Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream)
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 320
|
Tramadol Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 321
|
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Allen Loyd V Jr
|
May/Jun 2020
Pg. 180
|
Quality Control: Photostability of Compounded Preparations
Allen Loyd V Jr
|
May/Jun 2020
Pg. 200-205
|
Basics: Excipients Used in Nonsterile Compounding, Part 6: Compounding with Viscosity-increasing Agents
Allen Loyd V Jr
|
May/Jun 2020
Pg. 206-212
|
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates
Allen Loyd V Jr
|
May/Jun 2020
Pg. 215-220
|
Baclofen 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2020
Pg. 224
|
Dexamethasone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2020
Pg. 225
|
Diphenylcyclopropenone 0.1% or 3% in Isopropranol
Allen Loyd V Jr
|
May/Jun 2020
Pg. 226
|
Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules
Allen Loyd V Jr
|
May/Jun 2020
Pg. 227
|
Monsel's Solution, Gel, and Paste
Allen Loyd V Jr
|
May/Jun 2020
Pg. 228
|
Prednisolone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2020
Pg. 229
|
Sildenafil 2.5 mg/mL in Methylcellulose 1%:Syrup (1:1) Oral Suspension
Allen Loyd V Jr
|
May/Jun 2020
Pg. 230
|
Tetracycline Hydrochloride 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2020
Pg. 231
|
Ursodiol 100 mg/mL in Cod Liver Oil, Veterinary
Allen Loyd V Jr
|
May/Jun 2020
Pg. 232
|
Venlafaxine 15 mg/mL in Ora-Plus:Ora-Sweet (1:1) Suspension
Allen Loyd V Jr
|
May/Jun 2020
Pg. 233
|
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 92
|
Basics of Nonsterile Compounding: Excipients Used in Nonsterile Compounding, Part 5: Compounding Using Solvents and Cosolvent Systems
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 114-118
|
Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 121-126
|
Acetazolamide 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 130
|
Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 131
|
Glycopyrrolate 0.2 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 132
|
Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 133
|
Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 134
|
Propylthiouracil 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 135
|
Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 136
|
Terbinafine 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 137
|
Topiramate 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 138
|
Valsartan 4 mg/mL in Syrup NF
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 139
|
PreScription: One Size Does Not Fit All!
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 4
|
Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 38-43
|
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 44-50
|
Amiodarone Hydrochloride 5 mg/mL in SyrSpend SF pH4 Cherry Flavored
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 54
|
Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 55
|
Glycopyrrolate 0.2 mg/mL in Methylcellulose 1% and Syrup
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 56
|
Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 57
|
Isoniazid 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 58
|
LCD 5%, Salicylic Acid 6% in Clobetasol Propionate 0.05% Ointment
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 59
|
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 60
|
Potassium Chloride 1 mmol/mL in Ora-Sweet SF
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 61
|
Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 62
|
Venlafaxine 15 mg/mL in Syrup
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 63
|
PreScription: As Things Change….
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 444
|
Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 472-477
|
Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 478-482
|
Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 486
|
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 487
|
Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 488
|
Riboflavin 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 489
|
Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 490
|
Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 491
|
Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 492
|
Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 493
|
Verapmail Hydrochloride 50 mg/mL in SyrSpend SF
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 494
|
Zonisamide 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 495
|
PreScription: Regulations, Laws, Standards, Guidelines, Procedures, Etc
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 356
|
Basics: Excipients Used in Nonsterile Compounding, Part 2
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 393-396
|
Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 399-402
|
Allopurinol 20 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 406
|
Amitriptyline Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 407
|
Dipyridamole 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 408
|
Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted)
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 409
|
Oxandrolone 3 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 410
|
Sorafenib Capsules for Pediatric Use
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 411
|
Valsartan 4 mg/mL in Vehicle for Oral Solution USP
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 412
|
Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 413
|
PreScription: Temperatures by Degrees
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 268
|
Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 299-303
|
Basics: Excipients Used in Nonsterile Compounding, Part 1
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 305-311
|
Aripiprazole 1 mg/mL in Oral-Plus:Ora-Sweet (1:1) Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 314
|
Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 315
|
Domperidone 5 mg/mL in Oral Mix
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 316
|
Lorazepam 1 mg/mL in Anhydrous Organic Solvent System
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 317
|
Morphine Sulfate 0.2-mg/mL Solution Stored in Amber Oral Plastic Syringes
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 318
|
Rifampin 25 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 319
|
PreScription: Honesty/Ethics in Professions: The Gallup Polls
Allen Loyd V Jr
|
May/Jun 2019
Pg. 180
|
Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 1: Physical and Chemical Testing
Allen Loyd V Jr
|
May/Jun 2019
Pg. 211-216
|
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Allen Loyd V Jr
|
May/Jun 2019
Pg. 221-228
|
Aripiprazole 1 mg/mL in Methylcellulose 1% Syrup Oral Suspension
Allen Loyd V Jr
|
May/Jun 2019
Pg. 230
|
Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2019
Pg. 231
|
Clopidogrel 5 mg/mL in a Sugar-Free Syrup
Allen Loyd V Jr
|
May/Jun 2019
Pg. 232
|
Flunisolide Nasal Spray
Allen Loyd V Jr
|
May/Jun 2019
Pg. 233
|
Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2019
Pg. 234
|
Methotrexate 2-mg/mL Oral Solution
Allen Loyd V Jr
|
May/Jun 2019
Pg. 235
|
Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet
Allen Loyd V Jr
|
May/Jun 2019
Pg. 236
|
Valsartan 16-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2019
Pg. 237
|
PreScription: Compounding with Cannabidiol
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 92
|
Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding?
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 123-130
|
Basics of Compounding: Summary of the Official United States Pharmacopeia Monographs for Compounded Preparations
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 135-143
|
Acetaminophen 50% Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 146
|
Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 147
|
Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 148
|
Dexamethasone 2 mg/g Topical Paste, Veterinary
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 149
|
Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 150
|
Perphenazine 0.5 mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 151
|
Rosuvastatin 20-mg/5-mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 152
|
Tacrolimus 0.5 mg/mL in Oral Mix Suspension
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 153
|
PreScription: The Cost of Information
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 4
|
Basics of Compounding: Standardization of Compounded Medications
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 35-44
|
Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 52
|
Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 53
|
Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 54
|
Magnesium Sulfate and Lidocaine Hydrochloride Injection in Prefilled Syringes
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 55
|
Methimazole 5 mg/0.1 mL in Pluronic Lecithin Organogel Gel, Veterinary
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 56
|
Minoxidil 1-mg/mL in Ora-Plus and Ora-Sweet SF Suspension
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 57
|
Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 58
|
Orodispersible Film
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 59
|
Piperacillin 10 mg/mL in 0.9% Sodium Chloride Bladder Irrigation
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 60
|
Thiamine Hydrochloride 100 mg/mL in SurSPend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 61
|
PreScription: Standardized Concentrations: Pro or Con?
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 444
|
Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 492
|
Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 493
|
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 494
|
Hydrocortisone 2 mg/mL in Inorpha Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 495
|
Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 496
|
Prednisone 5 mg/mL ir Oral Mix Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 497
|
Errata
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 527
|
PreScription: Updating Formulations
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 356
|
Cysteamine 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 408
|
Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 409
|
Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 410
|
Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 411
|
PreScription: Factors Related to Drug Waste and Pharmacy Solutions
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 268
|
Quality Control: Water Activity Considerations for Beyond-use Dates
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 288-293
|
Basics of Compounding--Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 2
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 294-300
|
Anhydrous Medium-chain Triglycerides Gel
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 316
|
Budesonide 1-mg//10-mL Mucolox Oral Suspensions
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 317
|
Cinacalcet 5-mg/mL in Oral-Plus/Ora-Sweet Suspension
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 318
|
Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 319
|
Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 320
|
Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 321
|
Minoxidil 50 mg/mL in Espumil Foam Base
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 322
|
Oseltamivir Phosphate 15 mg/mL in SyrSpend SF
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 323
|
Pentoxifylline 5% in Dermabase
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 324
|
Propranolol Hydrochloride 1 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 325
|
PreScription: Influence and Sphere of Influence
Allen Loyd V Jr
|
May/Jun 2018
Pg. 180
|
Quality Control–Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding
Allen Loyd V Jr
|
May/Jun 2018
Pg. 206-217
|
Basics of Compounding–Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 1
Allen Loyd V Jr
|
May/Jun 2018
Pg. 220-228
|
Anhydrous Silicon Base Topical Gel Vehicle
Allen Loyd V Jr
|
May/Jun 2018
Pg. 232
|
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2018
Pg. 233
|
Dorzolamide 2% Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 2018
Pg. 234
|
Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
|
May/Jun 2018
Pg. 235
|
Pyrimethamine 2 mg/mL in Ora-Plus and Ora-Sweet Oral Suspension
Allen Loyd V Jr
|
May/Jun 2018
Pg. 236
|
Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture
Allen Loyd V Jr
|
May/Jun 2018
Pg. 237
|
Simvastatin 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
May/Jun 2018
Pg. 238
|
Trimethoprim 20 mg/mL and Sulfadiazine 100 mg/mL in Suspendit Oral Suspension
Allen Loyd V Jr
|
May/Jun 2018
Pg. 239
|
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 92
|
Pharmacogenomics: Precision Pharmacy in 503A Compounding
Drummond Joseph, Bennet Daron, Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 95-107
|
Basics of Compounding: Compounding Microemulsions
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 137-143
|
Clonidine Hydrochloride 10 mg/mL in Inorpha Solution
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 146
|
Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 147
|
Lamotrigine 1-mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 148
|
Levodopa and Carbidopa Rectal Suspension
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 149
|
Prochlorperazine Edisylate 0.5% Nasal Spray
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 150
|
Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 151
|
Spironolactone 5-mg/mL in Suspendit Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 152
|
Trilostane 5-mg/mL in Cod Liver Oil Suspension (Vet)
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 153
|
PreScription: 2017--Some Good Things Happened and Some Others
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 4
|
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 7-16
|
Glutamate and Aspartate Cardioplegia Additive Solution
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 50
|
Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 51
|
Metronidazole 50 mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 52
|
Miconazole 10% in Recura Topical Cream
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 53
|
Naproxen 25 mg/mL in Oral Mix or Oral Mix SF
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 54
|
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 55
|
Ranitidine 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 56
|
Sodium Citrate 9% Nasal Spray for Olfactory Disorders
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 57
|
Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 58
|
Voriconazole 40-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 59
|
PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 444
|
Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 481-486
|
Amitriptyline 20 mg/mL in OraPlus:OraSweet Suspension
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 490
|
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 491
|
Fluconazole 10% in RECURA Cream
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 492
|
Haloperidol 5-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 493
|
Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 494
|
Promethazine Hydrochloride 12.5 mg/0.1 mL in PLO Gel
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 495
|
Spironolactone 5 mg/mL in SuspendIt Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 496
|
Tolmetin 400-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 497
|
Trace Elements Injection 5
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 498
|
Vancomycin 5-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 499
|
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 356
|
Child-safety Containers/Devices and Compounding
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 364-370
|
Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 388-392
|
Acetylcysteine Solutions for Inhalation
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 408
|
Carbamazepine 25-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 409
|
Etoposide 20-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 410
|
Fentanyl Citrate 50-mcg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 411
|
Fluoxymesterone 10-mg Capsules
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 412
|
Ioversol Injection
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 413
|
Levocarnitine 100-mg/mL Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 414
|
Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 415
|
Tacrolimus 0.3-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 416
|
Vancomycin 50 mg/mL in Oral Syrup Suspension
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 417
|
PreScription: Just Think About It!
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 268
|
Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 293-298
|
Betamethasone 0.1% and Neomycin 0.6% Gel-Cream
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 312
|
Castor Oil 50% in Modified Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 313
|
Copper Sulfate, Magnesium Sulfate, Phenylephrine, and Guaifenesin Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 314
|
Disopyramide 100-mg Capsules
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 315
|
Ferrous Sulfate 30-mg Fe/mL Oral Drops
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 316
|
Reteplase Injection
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 317
|
Sertraline Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 318
|
Tacrolimus 0.06% Ophthalmic Drops
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 319
|
Torsemide 10-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 320
|
Tranilast 8% Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 321
|
PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives
Allen Loyd V Jr
|
May/Jun 2017
Pg. 180
|
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 2
Allen Loyd V Jr
|
May/Jun 2017
Pg. 215-220
|
Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2017
Pg. 232
|
Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
May/Jun 2017
Pg. 233
|
Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Allen Loyd V Jr
|
May/Jun 2017
Pg. 234
|
Meloxicam 1% Topical Gel
Allen Loyd V Jr
|
May/Jun 2017
Pg. 235
|
Ofloxacin 0.3% Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 2017
Pg. 236
|
PVP Iodine 10% Antiseptic Cream
Allen Loyd V Jr
|
May/Jun 2017
Pg. 237
|
Tri-Est, Progesterone, and Testosterone in Versatile, Phytobase, Fitaline, and HRT Supreme Cream Bases
Allen Loyd V Jr
|
May/Jun 2017
Pg. 238
|
Trimethoprim 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2017
Pg. 239
|
PreScription: Whatever Happened to Common Sense?
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 92
|
Quality Control: (Material) Safety Data Sheets
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 118-124
|
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 127-130
|
Azathioprine 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 146
|
Candesartan Cilexetil 8 mg Liquid-Filled Capsules
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 147
|
Furosemide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 148
|
Ketoconazole 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 149
|
PreScription: Compounding Pharmacy Issues for 2017
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 4
|
Analytic Methods Used in Quality Control in a Compounding Pharmacy
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 31-37
|
Basics of Compounding with Dilutions and Concentrates
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 39-45
|
Clindamycin 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 60
|
Diazoxide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 61
|
Infliximab 1% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 62
|
Nifedipine 0.5% Rectal Ointment
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 63
|
Tetracaine Hydrochloride 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 64
|
Zonisamide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 65
|
PreScription: Two Decades of IJPC
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 444
|
Introduction to Quality Control in a Compounding Pharmacy
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 481-484
|
Basics of Compounding: Clinical Pharmaceutics, Part 2
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 485-493
|
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 495-500
|
Alendronate 70-mg/75-mL Drinkable Formulation
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 504
|
Bosentan 6.25-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 505
|
Capsaicin 0.025% and Doxepin 3.3% Cream
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 506
|
Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 507
|
Erlotinib 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 508
|
Flumazenil 0.1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 509
|
Imatinib 40-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 510
|
Lapatinib Ditosylate 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 511
|
Melatonin 2-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 512
|
Menthol, Chloral Hydrate, and Camphor Analgesic Ointment
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 513
|
PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 356
|
Basics of Compounding: Clinical Pharmaceutics, Part 1
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 389-396
|
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 399-404
|
Clobazam 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 406
|
Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 407
|
Inamrinone 5-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 408
|
Levetiracetam 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 409
|
Naproxen 5% Cream
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 410
|
Permethrin 1% Lotion
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 411
|
Progesterone 10% Cream
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 412
|
Sodium Phosphate Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 413
|
Tetracaine Hydrochloride 2% Topical Solution
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 414
|
Tromethamine Injection
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 415
|
PreScription: Is the United States Pharmacopeial Convention, Inc., Authorized to Establish "Official" Practice Standards for Pharmacy, Medicine, and Nursing?
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 268
View Sample |
Basics of Compounding: Compounding Films
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 298-305
|
Dolasetron Mesylate 20-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 318
|
Gatifloxacin 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 319
|
Mebendazole 100-mg Capsules
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 320
|
Neomycin Sulfate 25-mg/mL Oral Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 321
|
Nystatin 100,000-units Vaginal Inserts
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 322
|
1,2-Octanediol 5% Topical Liquid
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 323
|
Phytonadione 1-mg/mL Oral Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 324
|
Plasmingen and Hyaluronate Sodium Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 325
|
Scopolamine Hydrobromide 0.25% Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 326
|
Tretinoin 10-mg Oral Capsules
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 327
|
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 351
View Sample |
PreScription: Patient Access to Pharmaceuticals
Allen Loyd V Jr
|
May/Jun 2016
Pg. 180
|
Basics of Compounding: Special Capsules
Allen Loyd V Jr
|
May/Jun 2016
Pg. 209-214
|
Carboplatin 50-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2016
Pg. 226
|
Cefotetan Disodium Injection
Allen Loyd V Jr
|
May/Jun 2016
Pg. 227
|
Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment
Allen Loyd V Jr
|
May/Jun 2016
Pg. 228
|
Dexpanthenol 5% Nasal Spray
Allen Loyd V Jr
|
May/Jun 2016
Pg. 229
|
Indomethacin Gel
Allen Loyd V Jr
|
May/Jun 2016
Pg. 230
|
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
|
May/Jun 2016
Pg. 231
|
Montelukast Sodium 5-mg Fast-Dissolving Film
Allen Loyd V Jr
|
May/Jun 2016
Pg. 232
|
Pain-Away II Headache Capsules
Allen Loyd V Jr
|
May/Jun 2016
Pg. 233
|
Sodium Nitroprusside 25-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2016
Pg. 234
|
Zolpidem Tartrate 5-mg and 10-mg Capsules
Allen Loyd V Jr
|
May/Jun 2016
Pg. 235
|
PreScription: Compounding: A Changing Paradigm
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 92
|
Basics of Compounding: Capsules
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 125-134
|
Blue Goo Anti-Itch Gel
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 144
|
Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 145
|
Medicated Polyox Bandage for Skin Ulcers
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 146
|
Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 147
|
PreScription: Starting Year 20!
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 4
|
Aprepitant 80-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 48
|
Aripiprazole 10-mg Oral Dissolving Tablets
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 49
|
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 50
|
Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 51
|
Mupirocin Calcium 2% Cream
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 52
|
Resveratrol, Tocopherol Acetate, and Niacinamide Topical Gel-Cream
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 53
|
Thrombin 1,000 Units/mL Topical Solution, Sterile
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 54
|
Tropicamide 1% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 55
|
Vancomycin 5% and Amikacin 2% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 56
|
Voriconazole 10-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 57
|
PreScription: The Documented Past and the Exciting Future
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 442
|
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 487-488
|
Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 504
|
Cefepime Hydrochloride 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 505
|
Cefotaxime 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 506
|
Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 507
|
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 508
|
Estradiol Valerate 40-mg/mL in Oil Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 509
|
Levetiracetam 100-mg/mL Injection (Concentrate)
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 510
|
Memantine Hydrochloride Capsules
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 511
|
Mupirocin 2% Nasal Ointment
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 512
|
Propranolol Hydrochloride Capsules
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 513
|
PreScription: Failure or Success?
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 354
|
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 389-390
|
Aminocaproic Acid 250-mg/mL Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 404
|
Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 405
|
Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 406
|
Nimodipine 3-mg/mL Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 407
|
Ofloxacin 0.3% Otic Solution
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 408
|
Povidone Iodine 10% Cold Sore Paint
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 409
|
Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 410
|
Vehicle for Oral Solution (National Formulary 26)
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 411
|
Vehicle for Oral Solution, Sugar Free (National Formulary 26)
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 412
|
Vehicle for Oral Suspension (National Formulary 26)
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 413
|
PreScription: 2015 Student Pharmacist Compounding Competition
Allen Loyd V Jr
|
May/Jun 2015
Pg. 180
|
Basics of Compounding: Compounding with Silicones
Allen Loyd V Jr
|
May/Jun 2015
Pg. 223-230
|
Atropine Sulfate 1% Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 2015
Pg. 242
|
Lidocaine Hydrochloride 2% Viscous Oral Topical Solution
Allen Loyd V Jr
|
May/Jun 2015
Pg. 243
|
Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches
Allen Loyd V Jr
|
May/Jun 2015
Pg. 244
|
Phenazopyridine Hydrochloride 200-mg Capsules
Allen Loyd V Jr
|
May/Jun 2015
Pg. 245
|
Physostigmine Salicylate 1-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2015
Pg. 246
|
Scopolamine Hydrobromide -.4-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2015
Pg. 247
|
PreScription: Some of the Best Sermons are Lived, not Preached!
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 92
|
Acne Scrub
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 142
|
Aminohippurate Sodium 200-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 143
|
Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 144
|
Heparin 335-United/Gram Gel-Cream
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 145
|
L-Cysteine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 146
|
Morrhuate Sodium 5% Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 147
|
Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 148
|
Pancuronium Bromide 1-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 149
|
Physostigmine Salicylate 1-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 150
|
Trypan Blue 0.06% Ophthalmic Solution
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 151
|
PreScription: 2014 in Review
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 4
|
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 38-40
|
Quality Control Analytical Methods: Refractive Index
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 43-47
|
Basics of Compounding: The Revised "Not to Compound List"
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 57-58
|
Atenolol 25-, 50-, or 100-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 60
|
Azathioprine 50-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 61
|
Cisplatin 1-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 62
|
Daunorubicin 5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 63
|
Erythromycin 50-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 64
|
Hydralazine Hydrochloride 20-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 65
|
Hydroxychloroquine Sulfate 200-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 66
|
Lidocaine Hydrochloride 4% Topical Solution
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 67
|
Mupirocin 2% Ointment
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 68
|
Phentolamine Mesylate 5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 69
|
PreScription: "Named Formulas" Database Available
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 444
|
Basics of Compounding: Tips and Hints, Part 6: Prescription Evaluation, Calculations, Ingredients, Quality-Assurance Practices, Patient Counseling, Shipping and Distribution, Miscellaneous
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 486-488
|
Clarithromycin 250-mg or 500-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 494
|
Dexmedetomidine 100 mcg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 495
|
Dexmethylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 496
|
Leucovorin 10-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 497
|
Levocarnitine 200-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 498
|
Methazolamide 25-mg or 50-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 499
|
Methylene Blue 10-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 500
|
Methylphenidate Hydrochloride 10-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 501
|
Oxacillin Sodium 167-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 502
|
Tamsulosin Hydrochloride 0.2-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 503
|
PreScription: What is a Compounding Pharmacist?
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 356
|
Basics of Compounding: Tips and Hints, Part 5: Facilities and Equipment
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 401-404
|
Azithromycin 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 408
|
Bacitracin Topical Ointment
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 409
|
Dexpanthenol 250-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 410
|
Ephedrine Sulfate 50-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 411
|
Fluorescein 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 412
|
Indocyanine green 2.5-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 413
|
Phenylephrine Hydrochloride 2.5%-Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 414
|
Sulfamethoxazole and Trimethoprim Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 415
|
Sumatriptan Succinate 12-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 416
|
Tranexamic Acid 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 417
|
Choline Magnesium Trisalicylate Liquid
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 327
|
Denileukin Diftitox 150-mcg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 328
|
Indigo Carmine Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 329
|
Propranolol Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 330
|
Zinc 1-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 331
|
PostScription: Responsibilities of a Compounding Pharmacist
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 351
|
PreScription: Challenging Times
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 268
|
Basics of Compounding Sterile Preparations: Nomenclature and Considerations
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 313-317
|
Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 318-319
|
Atracurium Besylate 10-mg/mL Injection, Preserved
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 322
|
Barium Sulfate Suspension
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 323
|
Calcitriol 1-mcg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 324
|
Chloramphenicol 100-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 325
|
Chlorothiazide 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 326
|
PreScription: Déjà Vu All Over Again
Allen Loyd V Jr
|
May/Jun 2014
Pg. 180
|
Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams
Allen Loyd V Jr
|
May/Jun 2014
Pg. 228-230
|
Atorvastatin 10-mg or 20-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 232
|
Bumetanide 0.5-mg, 1-mg, or 2-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 233
|
Bupivacaine Hydrochloride 0.5% Injection
Allen Loyd V Jr
|
May/Jun 2014
Pg. 234
|
Butorphanol Tartrate 10-mg/mL Nasal Spray
Allen Loyd V Jr
|
May/Jun 2014
Pg. 235
|
Dibucaine 1% Ointment
Allen Loyd V Jr
|
May/Jun 2014
Pg. 236
|
Lidocaine Hydrochloride 1% Injection
Allen Loyd V Jr
|
May/Jun 2014
Pg. 237
|
Methotrexate 2.5-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 238
|
Naproxen 25-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2014
Pg. 239
|
Tamoxifen 10-mg or 20-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 240
|
Thiothixene 1-mg, 2-mg, 5-mg, or 10-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 241
|
PreScription: Standards vs Opinions
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 92
|
Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 131-134
|
Basics of Compounding: Tips and Hints, Part 2: Compounding with Solutions, Suspensions, Emulsions, and Lotions
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 137-138
|
Doxazosin 1-mg, 2-mg, 4-mg, or 8-mg Capsules
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 142
|
Fludarabine Phosphate 25-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 143
|
Mecasermin 10-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 144
|
Methylprednisolone 40-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 145
|
Polymixin B Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 146
|
Rocuronium Bromide 10-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 147
|
Secretin 4 mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 148
|
Selenium 40-mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 149
|
Sincalide 1-mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 150
|
Testosterone Enanthate 200-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 151
|
PreScription: The International Journal of Pharmaceutical Compounding Begins Its 18th Year
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 4
|
Tips and Hints: Powders, Capsules, Tablets, Suppositories, and Sticks
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 42-45
|
Aztreonam Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 60
|
Bumetanide 0.25-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 61
|
Droperidol 2.5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 62
|
Lomustine 100-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 63
|
Neostigmine Bromide 15-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 64
|
Nimodipine 30-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 65
|
Phenobarbital 60-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 66
|
Potassium Chloride 2-mEq/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 67
|
Procainamide Hydrochloride 100-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 68
|
Vasopressin 20-units/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 69
|
PreScription: Two Milestones for the International Journal of Pharmaceutical Compounding
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 444
|
Physicians, Pharmacists, and the Importance of Quality Pharmacy Compounding
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 477-479
|
Basics of Compounding: Basics of Compounding with Balsams
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 490-495
|
Benztropine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 498
|
Cefazolin 250-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 499
|
Ciprofloxacin 250-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 500
|
Cortisone Acetate 25-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 501
|
Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 502
|
Dihydroergotamine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 503
|
Hydrocortisone 50-mg/mL Injection (as the Sodium Succinate)
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 504
|
Levothyroxine Sodium 100-mcg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 505
|
Metyrosine 250-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 506
|
Phenytoin Sodium 50-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 507
|
PostScription: Augmented Reality for Readers and Authors
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 526-527
|
PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 356
|
Basics of Compounding: Basics of Compounding with Tars
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 400-410
|
Acyclovir 50-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 414
|
Aminocaproic Acid 250-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 415
|
Clindamycin 150-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 416
|
Fluorouracil 50-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 417
|
Hydroxyzine Hydrochloride 25-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 418
|
Indomethacin 1-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 419
|
Mesna 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 420
|
Methotrexate 25-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 421
|
Phenylephrine Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 422
|
Terbutaline Sulfate 1-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 423
|
PostScription: GMPs vs. GCPs: United States Pharmacopeia General Chapters
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 439
|
Prescription: International Journal of Pharmaceutical Compounding and MEDLINE Update
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 268
|
Basics of Compounding: Foam Dosage Forms
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 312-322
|
Acyclovir 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 326
|
Acyclovir 200-mg Capsules
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 327
|
Allopurinol Sodium 4-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 328
|
Amikacin Sulfate 250-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 329
|
Dacarbazine 200-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 330
|
Ketamine 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 331
|
Methohexital Sodium 500-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 332
|
Metoprolol Tartrate 1-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 333
|
Rifampin 300-mg and Isoniazid 150-mg Capsules
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 334
|
Succinylcholine Chloride 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 335
|
PostScription: Traditional vs Nontraditional Pharmacy
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 351
|
PreScription: Compounding for Drug Shortages
Allen Loyd V Jr
|
May/Jun 2013
Pg. 180
|
Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations
Allen Loyd V Jr
|
May/Jun 2013
Pg. 210-219
|
Basics of Compounding: Potency and Stability Testing
Allen Loyd V Jr
|
May/Jun 2013
Pg. 220-224
|
Buffered Aspirin Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 228
|
Calcium Acetate 667-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 229
|
Estradiol 0.5-mg, 1-mg, or 2-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 230
|
Ethambutol 400-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 231
|
Isoniazid 300-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 232
|
Labetalol 50-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 233
|
Mercaptopurine 75-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 234
|
Naltrexone Hydrochloride 50-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 235
|
Prednisone 10-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 236
|
Reserpine 0.5-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 237
|
PreScription: Pharmacy Committees
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 92
|
Basics of Compounding: Repackaging, Part 2
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 136-140
|
Adenosine 3-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 144
|
Alcohol Dehydrated Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 145
|
Betahistine 16-mg Capsules
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 146
|
Ciprofloxacin 10-mg/mL Intravenous Injection Concentrate
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 147
|
Cyanocobalamin 1000-mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 148
|
Dexrazoxane 1-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 149
|
Meropenem 50-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 150
|
Paclitaxel 6-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 151
|
Thiotepa 15-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 152
|
Verapamil Hydrochloride 2.5-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 153
|
PreScription: How Many Pharmacies Compound and What Do They Compound?
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 4
|
Adrenal Fatigue
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 39-44
|
Quality Control: Analytical Methods: Calibration of Equipment and Calibration Curves
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 50-53
|
Basics of Compounding: Repackaging, Part 1
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 54-60
|
Desmopressin 4-mcg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 64
|
Dobutamine 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 65
|
Granisetron 1-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 66
|
Ibuprofen 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 67
|
Mepivacaine Hydrochloride 1% Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 68
|
Milrinone 0.2-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 69
|
Neostigmine Methylsulfate 0.5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 70
|
Nicardipine Hydrochloride Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 71
|
Octreotide 50-mcg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 72
|
Testosterone Cypionate 100-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 73
|
Errata
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 86
|
PostScription: GMPs and GCPs: A Topical Comparison
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 87
|
PreScription: A Degree in Pharmacy: How Valuable!
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 444
|
Colds and Cough
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 480-483
|
Quality Control: Analytical Methods. Certificates of Analysis, Part 1
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 486-488
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 490-496
|
Aminophylline 25-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 500
|
Ammonium Chloride 5-mEq/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 501
|
Azathioprine 10-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 502
|
Copper 0.4-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 503
|
Dipyridamole 5-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 504
|
Dopamine Hydrochloride 80-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 505
|
Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 506
|
Papaverine Hydrochloride 30-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 507
|
Valproate Sodium 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 508
|
Vercuronium Bromide 1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 509
|
PreScription: What Is Involved in the Making of Remington's?
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 356
|
Remington: The Science and Practice of Pharmacy: From the Past into the Future
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 358-362
|
Metronidazole 5-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 425
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 4: Cleaning and Packaging
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 405-414
|
Doxapram Hydrochloride 20-mg/mL injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 418
|
Enalaprilat 1.25-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 419
|
Esmolol Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 420
|
Fluconazole 2-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 421
|
Haloperidol 50-mg/mL in Oil Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 422
|
Meperidine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 423
|
Methocarbamol 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 424
|
Nalbuphine Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 426
|
Oxymorphone Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 427
|
PostScription: Remington Twenty-Second Edition
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 438
|
PreScription: Lifelong Learning
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 268
|
PreScription: Drug Shortages and Discontinued Drugs
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 268
|
A Concise Discussion of Headache Types, Part 3: Migraine
Williams LaVonn A, Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 270-274
|
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Allen Loyd V Jr, Williams LaVonn A
|
Jul/Aug 2012
Pg. 294-298
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 3: Testing
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 322-328
|
Betamethasone 0.6-mg/5-mL Syrup
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 332
|
Butorphanol Tartrate 2-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 333
|
Diphenhydramine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 334
|
Etomidate 2-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 335
|
Foscarnet Sodium 24-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 336
|
Ketorolac Tromethamine 15-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 337
|
Methyldopate Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 338
|
Ondansetron Hydrochloride 2-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 339
|
Sufentanil Citrate 50-mcg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 340
|
Tobramycin 40-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 341
|
PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare
Allen Loyd V Jr, Williams LaVonn A
|
Jul/Aug 2012
Pg. 350-351
|
PreScription: You're On Your Own
Allen Loyd V Jr
|
May/Jun 2012
Pg. 180
|
Treatment and Prevention of Insect Bites: Mosquitoes
Williams LaVonn A, Allen Loyd V Jr
|
May/Jun 2012
Pg. 210-218
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 2: Documentation and Verification
Allen Loyd V Jr
|
May/Jun 2012
Pg. 230-234
|
Acetazolamide 100-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 238
|
Alfentanil 500-mcg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 239
|
Ascorbic Acid 250-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 240
|
Diltiazem Hydrochloride 5-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 241
|
Famotidine 10-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 242
|
Metoclopramide 5-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 243
|
Naloxone Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 244
|
Orphenadrine Citrate 30-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 245
|
Prochlorperazine 5-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 246
|
Ranitidine 25-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 247
|
PreScription: Support the Organizations that Support You and Your Practice
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 92
|
Midazolam 5-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 162
|
Promethazine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 163
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 146-150
|
Amiodarone Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 154
|
Bupivacaine Hydrochloride 0.5% with Epinephrine 1:200,000 Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 155
|
Caffeine Citrate 20-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 156
|
Chromium 4-mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 157
|
Furosemide 10-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 158
|
Glycopyrrolate 0.2-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 159
|
Labetalol Hydrochloride 5-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 160
|
Lorazepam 4-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 161
|
Sodium Chloride 14.6% and 23.4% Injections
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 77
|
Sodium Phosphates Injection
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 78
|
Zinc 1-mg/mL and 5-mg/mL Injections
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 79
|
PreScription: Fifteen Years and Counting
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 4
|
Sodium Acetate 2-mEq/mL and 4-mEq/mL Injections
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 75
|
Sodium Bicarbonate 4.2%, 5.0%, 7.5%, and 8.4% Injections
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 76
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding–Nonsterile Preparations, Part 4
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 64-68
|
Calcium Chloride 10% Injection
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 70
|
Calcium Gluconate 10% Injection
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 71
|
Magnesium Sulfate 10% Injection (0.8 mEq/mL)
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 72
|
Potassium Acetate 2-mEq/mL and 4-mEq/mL Injections
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 73
|
Potassium Phosphates Injection
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 74
|
PreScription: Not All Pharmacists Should Compound!
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 444
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 3
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 488-496
|
Cefepime 1% Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 500
|
Citric Acid 3% Mouthrinse Solution
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 501
|
Dapsone 5% Topical Gel
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 502
|
Lavender Oil 4% in Polyethylene Glycol Ointment
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 503
|
Oxandrolone 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 505
|
Thioguanine 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 506
|
Tobramycin Fortified 13.5-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 507
|
Vancomycin 31-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 508
|
Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 504
|
Vancomycin 2% in Silver Sulfadiazine Cream
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 509
|
PreScription: Third-party Inequities and Discrimination
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 356
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 2
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 408-414
|
Carvedilol 0.625-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 418
|
Granisetron Hydrochloride 0.2-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 419
|
Lorazepam 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 420
|
Metoprolol Tartrate 1.25-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 421
|
Nifedipine 1-mg/500-mg Oral Powder
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 422
|
Nifedipine 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 423
|
Rebamipide Rectal Enema Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 424
|
Sotalol 5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 425
|
Sulfadiazine 100-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 426
|
Ursodiol 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 427
|
Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 308-315
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 1
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 328-331
|
Anesthetic Nasal Ointment
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 334
|
Citric Acid, Potassium Citrate, and Sodium Citrate Solution
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 335
|
Cromolyn Sodium 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 336
|
Glycopyrrolate 0.5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 337
|
Hydrocortisone 100-mg/60-mL Retention Enema
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 338
|
Magnesium Sulfate Paste
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 339
|
Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 342
|
Riboflavin 5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 343
|
PreScription: The Science and Technology of Hospital Pharmacy Newsletter
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 268
|
Methylprednisolone 4-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 340
|
Oxandrolone 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 341
|
PostScription: Announcement
Allen Loyd V Jr
|
May/Jun 2011
Pg. 262
|
PreScription: Greed Does Not Pay! Makena, Lucentis, and Others
Allen Loyd V Jr
|
May/Jun 2011
Pg. 180
|
Basics of Compounding: Basics of Compounding with Complex Organic Molecules
Allen Loyd V Jr
|
May/Jun 2011
Pg. 234-238
|
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
May/Jun 2011
Pg. 242
|
Diclofenac Sodium 1% Topical Gel
Allen Loyd V Jr
|
May/Jun 2011
Pg. 243
|
Ibuprofen 5% Topical Cream
Allen Loyd V Jr
|
May/Jun 2011
Pg. 244
|
Melatonin 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2011
Pg. 246
|
Sport Body Cooler
Allen Loyd V Jr
|
May/Jun 2011
Pg. 247
|
Tannic Acid 5% Alcohol Gel
Allen Loyd V Jr
|
May/Jun 2011
Pg. 248
|
Triamcinolone 0.1% Lotion
Allen Loyd V Jr
|
May/Jun 2011
Pg. 249
|
Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
May/Jun 2011
Pg. 245
|
Triclosan 2% Topical Cream
Allen Loyd V Jr
|
May/Jun 2011
Pg. 250
|
Wound Cleaner Solution
Allen Loyd V Jr
|
May/Jun 2011
Pg. 251
|
PreScription: Discontinued Drugs and Drug Shortages
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 92
|
Basics of Compounding: Basics of Compounding with Inorganic Salts
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 146-153
|
Acetylcysteine 1% or 10% Oral Solution
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 156
|
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 157
|
Clopidogrel 5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 158
|
Dextromethorphan Hydrobromide 15-mg Oral Film Strip
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 159
|
Hank's Balanced Salt Solution (Stock Solution)
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 160
|
Levamisole 25-mg/mL Oral Solution
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 161
|
Mandl's Paint
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 162
|
Massage Rub, Oil Free
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 163
|
Oral Film Strip Vehicle
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 164
|
Tea Tree Oil Acne Gel
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 165
|
Erratum: Stability of Venlafaxine Immediate-Release Suspensions
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 175
|
PreScription: The Resources of the International Journal of Pharmaceutical Compounding, Inc.; Sterile Compounding Meets Needs for Patients, Professionals
Allen Loyd V Jr, Menighan Thomas E
|
Jan/Feb 2011
Pg. 4
|
Basics of Compounding: Basics of Compounding with Potency Designated Ingredients
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 56-61
|
Diclofenac Sodium 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 64
|
Hydrocortisone Acetate 1% Gel, Alcohol-Free
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 65
|
Ibuprofen 5% Gel
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 66
|
Mandelic Acid 5% Cream
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 67
|
Methotrexate 30-mg/g Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 68
|
Piroxicam 1% Gel
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 69
|
Pramoxine 1% Cream
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 70
|
Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 71
|
Terbenafine Hydrochloride Bilayer Nail Lacquer
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 72
|
Vancomycin Hydrochloride 25-mg/mL Solution
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 73
|
Basics of Compounding: Basics of Compounding with Aliquots, Dilutions, and Concentrates
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 508-510
|
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 512
|
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 513
|
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 514
|
Capsaicin 0.05% Clear Medication Stick
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 517
|
Glutathione 25% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 518
|
Gramicidin 13% Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 519
|
Ketoprofen 2% Oral Gel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 521
|
PreScription: Compounding with Manufactured Products
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 448
|
Bromazepam 2.5-mg/mL Drops
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 515
|
Bromhexine Hydrochloride 0.8-mg/mL Syrup
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 516
|
Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 520
|
PreScription: Revised Format
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 358
|
Alpha-Bisabolol Mouthwash
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 420
|
Icy Blue Camphorated Gel
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 422
|
Carvedilol 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 423
|
Basics of Compounding: Basics of Compounding with Esters
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 416-418
|
Buspirone 2.5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 424
|
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 421
|
Triclosan 0.28% Mouthwash
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 425
|
Rufinamide 40-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 426
|
Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 427
|
Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 428
|
Polidocanol 0.5% Wound Spray
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 429
|
PreScription: Beginning of a New United States Pharmacopeial Convention, Inc., Cycle
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 268
|
Hygrometers and Thermohygrometers: Environmental Monitoring Ensures the Potency and Stability of Compounding Agents
Allen Loyd V Jr, McKenzie Robert, Ainsworth Ron, Kastango Eric S, Kaestner Rick, Rebelo Andre, Burnside Paul, Schultz Gerald
|
Jul/Aug 2010
Pg. 284-300
|
Acyclovir with Benzocaine Lip Balm
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 332
|
Acyclovir 5% Lip Balm with Dioxybenzone and Oxybenzone
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 333
|
Amitriptyline Hydrochloride Suppositories
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 334
|
Basics of Compounding: Basics of Compounding with Organic Salts
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 322-326
|
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program
Okeke Claudia C, Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 328-331
|
Ampicillin 250-mg Suppository
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 335
|
Antazoline Phosphate and Xylometazoline Hydrochloride Ophthalmic Drops
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 336
|
Buprenorphine Hydrochloride Injection
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 337
|
Chloroprocaine Hydrochloride Injection
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 338
|
Cyanocobalamin, Choline, and Niacinamide Injection
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 339
|
Fenoldopam Mesylate Injection
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 340
|
Flurbiprofen 5% Bioadhesive Gel for Gingivitis
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 341
|
PreScription: Quality Improvement in Pharmaceutical Compounding
Allen Loyd V Jr
|
May/Jun 2010
Pg. 180
|
Bacitracin 10,000-Units/mL Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 2010
Pg. 240
|
Carprofen 2.5-mg/mL Oral Suspension, Veterinary
Allen Loyd V Jr
|
May/Jun 2010
Pg. 241
|
Celecoxib 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 242
|
Basics of Compounding: Compounding with Hydrates and Solvates
Allen Loyd V Jr
|
May/Jun 2010
Pg. 222-229
|
Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations
Okeke Claudia C, Allen Loyd V Jr
|
May/Jun 2010
Pg. 232-238
|
Clozapine 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 243
|
Cohen's Rectal Ointment
Allen Loyd V Jr
|
May/Jun 2010
Pg. 244
|
Cyclophosphamide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 245
|
Lansoprazole 3-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 246
|
Rifaximin 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 247
|
Sunitinib 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 248
|
Voriconazole 40-mg/mL Oral Suspension, Veterinary
Allen Loyd V Jr
|
May/Jun 2010
Pg. 249
|
PreScription: The Ages of Man
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 92
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 18: Verification of Automated Compounding Devices for Parenteral Nutrition Compounding and Finished Preparation Release Checks and Tests
Allen Loyd V Jr, Okeke Claudia C
|
Mar/Apr 2010
Pg. 142-149
|
| Return to Top |
